BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20161030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160705
DTEND;VALUE=DATE:20161101
DTSTAMP:20260830T135327
CREATED:20160705T124949Z
LAST-MODIFIED:20160706T133740Z
UID:16333-1467676800-1477958399@ces.b2sg.org
SUMMARY:Postdoc in Epigenetics/Cancer (Brussels\, Belgium)
DESCRIPTION:A postdoctoral position is immediately available in the Laboratory of Cancer Epigenetics headed by Prof. François Fuks (ULB – Université Libre de Bruxelles/Free University of Brussels\, Belgium). \nYou will be expected to conduct cancer research in epigenetics and epigenomics. Specifically\, you will investigate the mechanisms and functions of a novel epigenetic modification. The following recent publication has direct relevance to this project: Delatte B\, et al.\, Science. 2016; 351:282-5. Genetic\, biochemical and cell biological as well as genome-wide approaches (e.g. RNA-Seq\, ChIP-Seq\, Infinium Methylation) will be applied. The lab is running a Next Generation Sequencing (NGS) Illumina platform: EPICS (http://epics.ulb.be/) and is part of the new ULB-Cancer Research Center (U-CRC) directed by Prof. Fuks\, encompassing fundamental\, translational and clinical research and providing an excellent scientific environment to conduct high profile research.\nWe are looking for a highly motivated candidate with extensive experience in molecular and cell biology. Applicants should hold a PhD degree in Biochemistry/Molecular Biology or related disciplines (or have recently submitted their thesis with their defence scheduled) and have published (or about to publish) in a peer reviewed journal. Experience in epigenetics/epigenomics would be an asset. \nThe position is funded for 3 years. Screening of applications begins immediately and continues until an outstanding candidate is selected. Flexible starting date. \nInformal enquiries\, a CV\, a motivation letter and names of two referees should be send to: Valentina Albarani (valentina.albarani@ulb.ac.be) \nLab website: http://www.ulb.ac.be/medecine/fukslab\nLab NGS platform: http://epics.ulb.be/ \nSelected publications:\n– Delatte et al. Science 2016\n– Delatte et al. Science Rep. 2015\n– Boumahdi et al. Nature 2014\n– Deplus et al. Cell Rep. 2014\n– Delatte et al. EMBO J. 2014\n– Deplus et al. EMBO J. 2013\n– Volkmar et al. EMBO J. 2012\n– Dedeurwaerder et al. EMBO Mol Med. 2011\n– Fuks F. Nature. 2010\n– Epsztejn-Litman Nat Struct Mol Biol. 2008\n– Villa et al. Cancer Cell. 2007\n– Brenner & Fuks Dev Cell. 2007\n– Viré et al. Nature 2006\n– Brenner et al. EMBO J. 2005
URL:https://ces.b2sg.org/event/postdoc-in-epigeneticscancer-brussels-belgium/
LOCATION:ULB\,  Université libre de Bruxelles Campus Erasme\, Anderlecht\, 1070\, Belgium
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2016/07/ULB-Epigenetics-lab.jpg
ORGANIZER;CN="ULB-Lab%20Cancer%20Epigenetics":MAILTO:epics@ulb.ac.be
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160706
DTEND;VALUE=DATE:20161101
DTSTAMP:20260830T135327
CREATED:20160706T131829Z
LAST-MODIFIED:20160706T133508Z
UID:16337-1467763200-1477958399@ces.b2sg.org
SUMMARY:PhD in Epigenetics/Cancer (Brussels\, Belgium)
DESCRIPTION:A PhD position is available in the Laboratory of Cancer Epigenetics headed by Prof. François Fuks at the Université libre de Bruxelles (ULB)\, Brussels\, Belgium. \nYou will be expected to conduct cancer research in epigenetics and epigenomics. Specifically\, you will investigate the mechanisms and functions of a novel epigenetic modification. The following recent publication has direct relevance to this project: Delatte B\, et al.\, Science. 2016; 351:282-5. Genetic\, biochemical and cell biological as well as genome-wide approaches (e.g. RNA-Seq\, ChIP-Seq\, Infinium Methylation) will be applied. The lab is running a Next Generation Sequencing (NGS) Illumina platform: EPICS\, and is part of the new ULB-Cancer Research Center (U-CRC) directed by Prof. Fuks\, providing an excellent scientific environment to conduct high profile research encompassing fundamental\, translational and clinical research. \nCandidates with a good first degree (BSc or MSc) in Biology\, Genetics\, Biochemistry or a related life science subject are all invited to apply. Preferred qualifications include excellent grades\, research talent (as proven by the master thesis) and personal ambition. Candidates are expected to have good academic writing and presentation skills. Screening of applications begins immediately and continues until an outstanding candidate is selected. \nThe position is funded for 3 years\, in the first instance. Screening of applications begins immediately and continues until an outstanding candidate is selected. The starting date is September 30\, 2016 at the latest. \nInformal enquiries\, a CV (including grades and class ranking)\, a motivation letter and names of three referees should be send to: Valentina Albarani (valentina.albarani@ulb.ac.be) \nLab website: http://www.ulb.ac.be/medecine/fukslab \nLab NGS platform EPICS: http://epics.ulb.be/ \nUniversity website: https://www.ulb.ac.be/ulb/presentation/uk.html \nSelected publications:\n– Delatte et al. Science 2016\n– Boumahdi et al. Nature 2014\n– Deplus et al. Cell Rep. 2014\n– Delatte et al. EMBO J. 2014\n– Deplus et al. EMBO J. 2013\n– Volkmar et al. EMBO J. 2012\n– Dedeurwaerder et al. EMBO Mol Med. 2011\n– Fuks F. Nature 2010\n– Villa et al. Cancer Cell 2007\n– Viré et al. Nature 2006
URL:https://ces.b2sg.org/event/phd-in-epigeneticscancer-brussels-belgium/
LOCATION:ULB\,  Université libre de Bruxelles Campus Erasme\, Anderlecht\, 1070\, Belgium
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2016/07/ULB-Epigenetics-lab.jpg
ORGANIZER;CN="ULB-Lab%20Cancer%20Epigenetics":MAILTO:epics@ulb.ac.be
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160913
DTEND;VALUE=DATE:20160918
DTSTAMP:20260830T135327
CREATED:20151229T231245Z
LAST-MODIFIED:20160105T162345Z
UID:12204-1473724800-1474156799@ces.b2sg.org
SUMMARY:Epigenetics and Chromatin
DESCRIPTION:You are cordially invited to participate in the third Cold Spring Harbor Laboratory meeting on Epigenetics & Chromatin. The opening session will begin at 7:30 pm on Tuesday\, September 13 and the meeting will end after lunch on Saturday\, September 17\, 2016. As currently planned\, the program will have eight sessions devoted to oral presentations\, together with three poster sessions for presentations which cannot be accommodated in the formal sessions. Selection of talks for the oral sessions will be made by the organizers in conjunction with the session chairpersons\, from the submitted abstracts.
URL:https://ces.b2sg.org/event/epigenetics-and-chromatin/
LOCATION:Unnamed Venue\, Cold Spring Harbor\, NY\, United States
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/CSH.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160914
DTEND;VALUE=DATE:20160917
DTSTAMP:20260830T135327
CREATED:20160426T133029Z
LAST-MODIFIED:20160426T134342Z
UID:15328-1473811200-1474070399@ces.b2sg.org
SUMMARY:Wellcome Genome Campus: Single Cell Genomics 2016
DESCRIPTION:Building on the success of previous single cell genomics meetings\, this year’s meeting will be held at the Wellcome Genome Campus\, Hinxton\, UK. \n\n\n\nSingle cell genomics is rapidly emerging as a revolutionary technology transforming many fields of biological research\, including immunology and cancer. Through its many applications (e.g. single cell genome sequencing\, single cell transcriptomics\, and various single cell epigenetic profiling approaches)\, researchers can characterize the genetic and functional properties of individual cells in their native conditions\, leading to numerous experimental and clinical opportunities. \nAs technology is developing\, many critical questions are arising: \n\nWhich technologies are going to set the standard in the field?\nHow many cells needed to be sampled? How should sampling be designed and optimized?\nHow can the behaviour of groups of hundreds or thousands of single cells be analysed and modelled?\nWhat is the importance of modelling when precise single-cell-states are available?\nHow can single cell genomics and epigenomics be integrated?\nWhat are the immediate implications for immunology\, cancer research and germ cells?\n\nThese questions will be the focus of discussions at this year’s meeting. This conference will bring together biologists\,  methods developers\, computational modellers and genomics researchers interested in understanding biological variation at the single cell level.
URL:https://ces.b2sg.org/event/wellcome-genome-campus-single-cell-genomics-2016/
LOCATION:Wellcome Genome Campus\, Hinxton\, Camebridge\, United Kingdom
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/Wellcome-Genome-Campus.png
END:VEVENT
END:VCALENDAR